CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Open-market buy Chief Medical Officer bought 4,000 shares at $14.15 ($56,600)
- 4 Open-market buy Director bought 35,000 shares at $14.07 ($492,527)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 1,000,000 shares at $17.00 ($17,000,000)
- 4 Open-market sale Chief Operating Officer sold 1,000 shares at $26.41 ($26,410)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $19.20 ($57,600)
- 4 Open-market sale Chief Operating Officer sold 6,000 shares at an average $20.58 ($123,484)
- 4 Open-market sale Chief Financial Officer sold 15,000 shares at $19.20 ($288,000)
- 4 Open-market sale Director sold 75,000 shares at $15.82 ($1,186,500)
- 4 Open-market sale 10% owner sold 75,000 shares at $15.82 ($1,186,500)
- 4 Open-market sale 10% owner sold 130,000 shares at an average $15.79 ($2,052,700)
- 4 Open-market sale Director sold 130,000 shares at an average $15.79 ($2,052,700)
- 4 Open-market sale 10% owner sold 21,480 shares at $15.71 ($337,451)
- 4 Open-market sale Director sold 21,480 shares at $15.71 ($337,451)
- 4 Open-market sale 10% owner sold 12,819 shares at $15.77 ($202,156)
- 4 Open-market sale Director sold 12,819 shares at $15.77 ($202,156)
Page 15 of 18 · 351 filings